Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Study Location:

Find another location


Questions to ask
Skip to Main Content

Keep up to date

Sign up for news and information about taking part and shaping research.

English | Cymraeg
Be Part of Research - Trial Details - Study of the Gut Hormone Analogue G3215 in Adult Subjects
Back

Study of the Gut Hormone Analogue G3215 in Adult Subjects

Completed

Open to: Male

Age: 18 Years - 60 Years

Leeds

Medical Conditions

Diabetes Mellitus
Obesity

This information is provided directly by researchers and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information.


A randomised, placebo controlled Phase I study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of G3215 in adult subjects.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

Jan 2015 Jan 2019

Interventional

Intervention Type : Drug
Intervention Description : Gut hormone analogue

Intervention Arm Group : 0.1 mg dose G3215 (A1);0.5 mg dose G3215 (A1);1.5 mg dose G3215 (A1);10 mg dose G3215 (A6);12 mg dose G3215 (A8);12-24 mg (B1) dose of G3215;16 mg dose G3215 (A9);3.2mg (C) infusion pump dose of G3215;32 mg dose G3215 (A10);4 mg dose G3215 (A2) with varied formulation;4 mg dose G3215 (A3) with varied formulation;4 mg dose G3215 (A4) with varied formulation;4 mg dose G3215 (A5) with varied formulation;48 mg dose G3215 (A11);5-16 mg (B3) dose of G3215;6-10 mg (B2) dose of G3215;8 mg dose G3215 (A7)

Intervention Type : Drug
Intervention Description : 0.9% saline

Intervention Arm Group : 3.2mg (C) infusion pump dose of G3215;Placebo (A) - saline;Placebo (B) - saline



You can take part if:



You may not be able to take part if:


This is in the inclusion criteria above


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Covance Clinical Research Unit
    Leeds
    LS2 9LH


The study is sponsored by Imperial College London and funded by Medical Research Council; Covance.



We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?
Read full details for Trial ID: NCT02692040
Last updated 25 November 2020

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.   

Back to the top